Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Curiel Cid, Rosie E.a; b; * | Ortega, Alexandraa; b | Vaillancourt, Davida; c | Asken, Bretona; d | Crocco, Elizabeth A.a; b | Armstrong, Melissa J.a; e | Duara, Ranjana; f | Crenshaw, Kirstenb | Adjouadi, Maleka; g | Rosselli, Monicaa; h | Wang, Wei-ena; c | Loewenstein, David A.a; b
Affiliations: [a] 1Florida Alzheimer’s Disease Research Center (ADRC), Miami, FL, USA | [b] Center for Cognitive Neuroscience and Aging (CNSA), Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA | [c] Department of Applied Physiology and Kinesiology, Gainesville, FL, USA | [d] Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA | [e] University of Florida College of Medicine, Gainesville, FL, USA | [f] Department of Neurology and The Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA | [g] Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA | [h] Department of Psychology, Florida Atlantic University, Boca Raton, FL, USA
Correspondence: [*] Correspondence to: Rosie E. Curiel Cid, PsyD, Professor of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging (CNSA), University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Suite 3202, Miami, FL 33136, USA. E-mail: [email protected].
Abstract: Background:Semantic intrusion errors (SIEs) are both sensitive and specific to PET amyloid-β (Aβ) burden in older adults with amnestic mild cognitive impairment (aMCI). Objective:Plasma Aβ biomarkers including the Aβ42/40 ratio using mass spectrometry are expected to become increasingly valuable in clinical settings. Plasma biomarkers are more clinically informative if linked to cognitive deficits that are salient to Alzheimer’s disease (AD). Methods:This study included 119 older adults enrolled in the 1Florida Alzheimer’s Disease Research Center (ADRC), 45 aMCI participants scored below the established Aβ42/40 ratio cut-off of 0.160 using the Quest AD-Detect™ assay indicating Aβ positivity (Aβ+), while 50 aMCI participants scored above this cut-off indicating Aβ negative status (Aβ–). Additionally, 24 cognitively unimpaired (CU) persons scored above the cut-off of 0.160 (Aβ–). Results:The aMCI plasma Aβ+ group evidenced the greatest percentage of SIEs, followed by the aMCI Aβ–. The CU Aβ– group exhibited the lowest percentage of SIEs. After adjustment for global cognitive impairment, aMCI plasma Aβ+ continued to demonstrate greater SIEs on tests tapping the failure to recover from proactive semantic interference (frPSI) as compared to the aMCI Aβ–group. Using pre-established cut-offs for frPSI impairment, 8.3% of CU Aβ– participants evidenced deficits, compared to 37.8% of aMCI Aβ–, and 74.0% of aMCI Aβ+. Conclusions:SIEs reflecting frPSI were associated with aMCI Aβ+ status based on the Aβ42/40 ratio. Results suggest the importance of SIEs as salient cognitive markers that map onto underlying AD pathology in the blood.
Keywords: Alzheimer’s disease, amyloid-β, Aβ42/40, LASSI-L, mild cognitive impairment, plasma biomarkers, semantic intrusion errors
DOI: 10.3233/JAD-240164
Journal: Journal of Alzheimer's Disease, vol. 101, no. 4, pp. 1195-1204, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]